Prescription Drugs - Research and Data from KFF

Consumer Protection Issues Raised by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

Jun 30, 2004

Report

This paper identifies and examines consumer protection issues that arise from the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Key issue areas include: beneficiary information, marketing, enrollment and disenrollment, the drug benefit package and cost-sharing, the appeals process, concerns for low-income beneficiaries, challenges for nursing home issues, and fraud and abuse. Report (.

Selected Findings on Knowledge and Understanding of the New Medicare Rx Drug Program — May/June 2004 Kaiser Health Poll Report Survey

Jun 30, 2004

Poll Finding

Topline findings from the May/June 2004 Kaiser Health Poll Report survey, including knowledge and opinions about the new Medicare prescription drug law. Survey Toplines (.

The New Medicare Prescription Drug Law: Issues for Dual Eligibles with Disabilities and Serious Conditions

Jun 29, 2004

Issue Brief

The New Medicare Prescription Drug Law: Issues for Dual Eligibles with Disabilities and Serious Conditions The new issue paper discusses the challenges the new Medicare drug program faces in meeting the needs of dual eligible individuals with disabilities, who tend to have extensive, complex and varying needs.

The New Medicare Rx Benefit: Challenges for Maintaining Access to Prescription Drugs

Jun 29, 2004

The New Medicare Drug Benefit: Potential Effects of Pharmacy Management Tools on Access to Medications

Jun 29, 2004

Issue Brief

The New Medicare Drug Benefit: Potential Effects of Pharmacy Management Tools on Access to Medications This report describes the pharmacy benefit management tools that will be available to private plans administering the new Medicare drug benefit, including formularies, the definition of categories and classes, and cost sharing requirements.

Additional Help with Rx Drug Costs For Low-Income People on Medicare

Jun 1, 2004

Issues Surrounding the “Clawback” or State Contributions Towards Medicare Drug Coverage: A Conference Call Discussion

Jun 1, 2004

Medicaid Prescription Drug Spending and Use

Jun 1, 2004

Issue Brief

This issue paper provides the latest data and trend analysis on Medicaid prescription drug spending and utilization. In 2002, Medicaid programs spent $30 billion for prescribed drugs. Issue Paper (.

The “Clawback:” State Financing of Medicare Drug Coverage

Jun 1, 2004

Issue Brief

This issue paper describes the origins of the clawback, the formula by which each state’s clawback amount is calculated, and the clawback’s implications for states and for low-income Medicare beneficiaries. Issue Paper (.

Trends in Medicare Supplemental Insurance and Prescription Drug Benefits, 1996-2001Data Update

May 31, 2004

Report

Trends in Medicare Supplemental Insurance and Prescription Drug Benefits, 1996-2001 Data Update This data update provides estimates of supplemental insurance and prescription drug coverage rates and trends between 1996 and 2001, which will help to provide important context for assessing future changes in supplemental insurance and drug coverage rates after provisions of the Medicare drug…

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

View the Latest: Prescription Drugs

Filter